Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Sandeep Ghorpade

Has grant

Head of Drug Discovery

University of Cape Town

South Africa

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Pharmaceutical Chemistry

Recent Grants

Grant: Open

AI/ML model for TB virtual screening

Open Date: 2025-09-01

Close Date: 2026-12-01

Grant: Close

FadD32 compound scale up

Open Date: 2024-10-01

Close Date: 2025-05-01

Grant: Close

Nuovi derivati pirazolici come potenziali agenti anti-tubercolari

Open Date: 2020-01-01

Close Date:

Grant: Close

Inhibitors of Mycobacterium tuberculosis FAS-II dehydratases

Open Date:

Close Date:

Articles (5)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Collaborators (5)

Lutete Peguy Khonde

Group Leader

Broad Institute

UNITED STATES

View details

Tanya Parish

Professor of Global Health Therapeutics

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

Lyn-Marie Birkholtz

Professor and Research Chair

Stellenbosch University

SOUTH AFRICA

View details

Marcus Lee

Professor

University of Dundee

UNITED KINGDOM

View details

Kathryn J Wicht

Lecturer and Research Group Leader

University of Cape Town

SOUTH AFRICA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sandeep Ghorpade

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (5)

Structure−Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors

Structure−Activity Relationship and Antituberculosis Properties of 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 Inhibitors [version 1]

Optimization of 2,8-didaryl-1,5-naphthyridines as <i>Plasmodium falciparum</i> phosphatidylinositol 4-kinase inhibitors with improved ADME profiles and in vivo efficacy

2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy.

Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents

Collaborators (5)

Lutete Peguy Khonde

Tanya Parish

Lyn-Marie Birkholtz

Marcus Lee

Kathryn J Wicht

Make your next move.

Sandeep Ghorpade

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (5)

Structure−Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors

Structure−Activity Relationship and Antituberculosis Properties of 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 Inhibitors [version 1]

Optimization of 2,8-didaryl-1,5-naphthyridines as <i>Plasmodium falciparum</i> phosphatidylinositol 4-kinase inhibitors with improved ADME profiles and in vivo efficacy

2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of &lt;i&gt;Plasmodium falciparum&lt;/i&gt; Phosphatidylinositol-4-kinase and Hemozoin Formation with &lt;i&gt;In Vivo&lt;/i&gt; Efficacy.

Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents

Collaborators (5)

Lutete Peguy Khonde

Tanya Parish

Lyn-Marie Birkholtz

Marcus Lee

Kathryn J Wicht

Make your next move.

2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of <i>Plasmodium falciparum</i> Phosphatidylinositol-4-kinase and Hemozoin Formation with <i>In Vivo</i> Efficacy.